| verifiedfields | changed |
|---|
| watchedfields | changed |
|---|
| verifiedrevid | 458449795 |
|---|
| width | 200 |
|---|
| routes of administration | Intranasal, inhalation, topical |
|---|
| atc prefix | D07 |
|---|
| atc suffix | AC17 |
|---|
| legal ca | OTC |
|---|
| bioavailability | 0.51% (Intranasal) |
|---|
| protein bound | 91.0% |
|---|
| metabolism | Intranasal
Liver (CYP3A4-mediated) |
|---|
| elimination half-life | 10 hours |
|---|
| excretion | Kidney |
|---|
| iuphar ligand | 6699 |
|---|
| cas number | 90566-53-3 |
|---|
| pubchem | 5311101 |
|---|
| drugbank | DB00588 |
|---|
| chemspiderid | 4470631 |
|---|
| unii | CUT2W21N7U |
|---|
| kegg | D07981 |
|---|
| chebi | 5134 |
|---|
| chembl | 1201396 |
|---|
| synonyms | 6α,9α-Difluoro-11β,17α-dihydroxy-16α-methyl-21-thia-21-fluoromethylpregna-1,4-dien-3,20-dione; S-(Fluoromethyl)-6α,9α-difluoro-11β,17α-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate |
|---|
| iupac name | S-fluoromethyl (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate |
|---|
| c | 22 |
|---|
| h | 27 |
|---|
| f | 3 |
|---|
| o | 4 |
|---|
| s | 1 |
|---|
| smiles | O=C(SCF)[C@]3(O)[C@]2(C[C@H](O)[C@]4(F)[C@@]/1(\C(=C/C(=O)\C=C\1)[C@@H](F)C[C@H]4[C@@H]2C[C@H]3C)C)C |
|---|
| stdinchi | 1S/C22H27F3O4S/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-19(15,2)21(14,25)17(27)9-20(13,3)22(11,29)18(28)30-10-23/h4-5,7,11,13-14,16-17,27,29H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19+,20+,21+,22+/m1/s1 |
|---|
| stdinchikey | MGNNYOODZCAHBA-GQKYHHCASA-N |
|---|
